Content by this expert
Recently published by Raphael
De-Risking Your Bioconjugate’s Development Path From Discovery To The Clinic
Bioconjugation, in its broadest definition, is the chemical modification of biomolecules to enhance...
From Early Development into Clinic - De-risking a Bioconjugates Journey
The journey of a novel bioconjugate into clinic is complex and uncertain. In this webinar, we...
A Q&A With The Experts: De-risking Your Bioconjugate’s Path To Clinical Manufacturing
The bioconjugate market has made significant progress since the approval of the first antibody drug...